Currently out of the existing stock ratings of Daniel Brims, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Daniel Brims

Work Performance Price Targets & Ratings Chart

Analyst Daniel Brims works at HC WAINWRIGHT with a stock forecast success ratio of 66.67% fulfilled within 39.33 days on average. Previously, Daniel Brims worked at HCWAINWRIGHT.

Daniel Brims’s has documented 17 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TTPH, Tetraphase Pharmaceuticals at 09-Sep-2015.

Wall Street Analyst Daniel Brims

Analyst best performing recommendations are on TTPH (TETRAPHASE PHARMACEUTICALS).
The best stock recommendation documented was for TTPH (TETRAPHASE PHARMACEUTICALS) at 9/9/2015. The price target of $220 was fulfilled within 9 days with a profit of $30.2 (15.91%) receiving and performance score of 17.68.

Average potential price target upside

TTPH Tetraphase Pharmaceuticals CMRX Chimerix MEIP MEI Pharma

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

3 years 11 months 14 days ago

1/2 (50%)

$36.05 (72.09%)

304

Buy

140

4 years 7 months 18 days ago

0/4 (0%)

$69.6 (98.86%)

Buy

380

4 years 11 months 11 days ago

0/3 (0%)

$224.8 (144.85%)

Buy

5 years 7 months 1 days ago

0/3 (0%)

$150.4 (116.05%)

Buy

140

$137.8 (6263.64%)

120

5 years 7 months 24 days ago

0/3 (0%)

$81.4 (104.62%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Daniel Brims?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?